Goethe Universität Frankfurt

Frankfurt am Main 60590

0 studies enrolling now · 2 studies all time

What they study most

Dermatitis, Atopic, Myelodysplastic Syndromes, Neoplasms, Non-Hodgkin Lymphoma, Solid Tumor, Adult

Studies at this site

• A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS — Completed
• A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis — Stopped early